Lessner Susan M, Martinson Deborah E, Galis Zorina S
Coulter Department of Biomedical Engineering, Emory University School of Medicine, WMB 2001, 101 Woodruff Circle, Atlanta, GA 30322, USA.
Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):2123-9. doi: 10.1161/01.ATV.0000141840.27300.fd. Epub 2004 Aug 12.
The compensatory arterial remodeling associated with atherosclerotic plaques is thought to rely on the activity of matrix metalloproteinases (MMP). To assess the role of MMP-9, we analyzed the effect of MMP-9 genetic deficiency on the development and remodeling of experimental atherosclerotic lesions induced in the apolipoprotein E (apoE) knockout (-/-) mouse model.
We analyzed remodeling parameters and cellular composition of experimental carotid artery atherosclerotic lesions in apoE-/- and apoE-/- MMP-9-/- double-knockout (DKO) mice at 0, 3, 7, and 14 days after induction by flow cessation. Morphometric image analysis of arterial tissue sections indicated that overall artery size, measured as area encompassed by the external elastic lamina, increased 3.1-fold in the apoE-/- mice but only 1.6-fold in the DKO mice (P<0.0001) by 14 days. At the same time, the net lesion area occupied by macrophages was similar. Statistical analysis indicated that the overall expansion of the artery was 2.5-fold less sensitive to macrophage content in DKO compared with apoE-/- mice. No compensatory increase in other gelatinolytic activities was detected in the DKO.
MMP-9 deficiency significantly impaired compensatory vessel enlargement during carotid artery lesion development in the apoE-/- mouse, without altering macrophage content of lesions.
与动脉粥样硬化斑块相关的代偿性动脉重塑被认为依赖于基质金属蛋白酶(MMP)的活性。为了评估MMP-9的作用,我们分析了MMP-9基因缺陷对载脂蛋白E(apoE)基因敲除(-/-)小鼠模型中实验性动脉粥样硬化病变的发展和重塑的影响。
我们分析了在血流停止诱导后0、3、7和14天,apoE-/-和apoE-/-MMP-9-/-双敲除(DKO)小鼠实验性颈动脉粥样硬化病变的重塑参数和细胞组成。动脉组织切片的形态计量图像分析表明,以外部弹性膜所包围的面积衡量的动脉总体大小,在apoE-/-小鼠中增加了3.1倍,但在DKO小鼠中到14天时仅增加了1.6倍(P<0.0001)。同时,巨噬细胞占据的净病变面积相似。统计分析表明,与apoE-/-小鼠相比,DKO小鼠中动脉的总体扩张对巨噬细胞含量的敏感性降低了2.5倍。在DKO中未检测到其他明胶酶活性的代偿性增加。
在apoE-/-小鼠的颈动脉病变发展过程中,MMP-9缺乏显著损害了代偿性血管扩张,而不改变病变中的巨噬细胞含量。